These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19342476)

  • 1. Salvage therapy in Hodgkin's lymphoma.
    Mendler JH; Friedberg JW
    Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
    Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma.
    Sureda A
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation in Hodgkin lymphoma.
    Murphy F; Sirohi B; Cunningham D
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):297-306. PubMed ID: 17338650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing relapsed and refractory Hodgkin lymphoma.
    Brice P
    Br J Haematol; 2008 Apr; 141(1):3-13. PubMed ID: 18279457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.
    Morschhauser F; Brice P; Fermé C; Diviné M; Salles G; Bouabdallah R; Sebban C; Voillat L; Casasnovas O; Stamatoullas A; Bouabdallah K; André M; Jais JP; Cazals-Hatem D; Gisselbrecht C;
    J Clin Oncol; 2008 Dec; 26(36):5980-7. PubMed ID: 19018090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A; Forman SJ
    Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
    Ballova V; Ladicka M; Vranovsky A; Lakota J
    Neoplasma; 2008; 55(5):428-36. PubMed ID: 18665754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of relapsed Hodgkin lymphoma.
    Cashen AF; Bartlett NL
    Blood Rev; 2007 Sep; 21(5):233-43. PubMed ID: 17683834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage therapy in Hodgkin's lymphoma.
    Byrne BJ; Gockerman JP
    Oncologist; 2007 Feb; 12(2):156-67. PubMed ID: 17296811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
    Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
    J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage therapy for Hodgkin's lymphoma.
    Quddus F; Armitage JO
    Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
    Claviez A; Sureda A; Schmitz N
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S16-24. PubMed ID: 18978738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.
    Daw S; Wynn R; Wallace H
    Br J Haematol; 2011 Feb; 152(3):249-60. PubMed ID: 21133886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
    Torjman L; Ladeb S; Lakhal A; Ben Othman T; Abdelkefi A; Ben Abdeladhim A
    Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Salvage therapy in relapsed or refractory malignant lymphoma].
    Kashimura T; Murohashi I
    Nihon Rinsho; 2000 Mar; 58(3):699-703. PubMed ID: 10741149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsed and refractory Hodgkin's lymphoma: new avenues?
    Canellos GP
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):929-41. PubMed ID: 17908629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment for relapsing patients with Hodgkin lymphoma.
    Sibon D; Brice P
    Expert Rev Hematol; 2009 Jun; 2(3):285-95. PubMed ID: 21082970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.